BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34702252)

  • 1. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
    Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
    Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():849592. PubMed ID: 35444654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer.
    Wang Z; Zhang S; Zheng C; Xia K; Sun L; Tang X; Zhou F; Ouyang Y; Tang F
    Int J Gen Med; 2022; 15():5701-5713. PubMed ID: 35755862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
    Meng C; Zhang Y; Jiang D; Wang J
    World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker.
    Fang T; Wang D; Li R; Yu W; Tian H
    Front Genet; 2022; 13():1035337. PubMed ID: 36568377
    [No Abstract]   [Full Text] [Related]  

  • 6. Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy.
    Jia Y; Guo B; Zhang W; Wang F; Zhang Y; Zhang Q; Li E
    Front Oncol; 2023; 13():1110207. PubMed ID: 37427102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer.
    Pan T; Wang S; Wang Z
    J Cancer; 2023; 14(10):1809-1836. PubMed ID: 37476180
    [No Abstract]   [Full Text] [Related]  

  • 8. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
    Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
    Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular mechanisms of CTHRC1 in gastric cancer by integrating TCGA, GEO and GSA datasets.
    Zhao L; Wang W; Niu P; Luan X; Zhao D; Chen Y
    Front Genet; 2022; 13():900124. PubMed ID: 35928443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors.
    Lin X; Xiao M; Chen Z; Ding C; Zhang T; Li Q
    J Oncol; 2022; 2022():6115878. PubMed ID: 35656340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis combined with experiments explores the oncogenic role of spindle apparatus coiled-coil protein 1 (SPDL1).
    Song P; Wusiman D; Li F; Wu X; Guo L; Li W; Gao S; He J
    Cancer Cell Int; 2022 Jan; 22(1):49. PubMed ID: 35093072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
    Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
    Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis.
    Zheng X; Chen L; Liu W; Zhao S; Yan Y; Zhao J; Tian W; Wang Y
    Hereditas; 2023 Mar; 160(1):13. PubMed ID: 36964635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer.
    Gao X; Bu H; Ge J; Gao X; Wang Y; Zhang Z; Wang L
    J Cancer; 2023; 14(13):2431-2442. PubMed ID: 37670965
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
    Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
    Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
    Wu X; Chen H; You C; Peng Z
    Hereditas; 2023 May; 160(1):21. PubMed ID: 37170390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERH Impacts Patient Prognosis and Tumor Immune Microenvironment: A Pan-Cancer Analysis.
    Gong Q; Li Q; Shen X; Xu Z
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38584561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.